ImageneBio (IMA) Non Operating Income (2022 - 2025)
ImageneBio (IMA) posted Non Operating Income of $1.7 million for Q3 2025, down 70.97% sequentially from $6.0 million in Q2 2025, and up 251.79% YoY from $494901.4 in Q3 2024.
ImageneBio (IMA) Non Operating Income (2022 - 2025) Analysis & Trends
ImageneBio has reported Non Operating Income for 4 years, with the latest figure at $1.7 million in Q3 2025.
- Quarterly Non Operating Income rose 251.79% year-over-year to $1.7 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $18.4 million (up 243.37% YoY) and the FY2024 annual result came in at $9.9 million, up 39.53% from the prior year.
- Non Operating Income slipped to $1.7 million in Q3 2025 per IMA's latest filing, from $6.0 million in the prior quarter.
- Over five years, Non Operating Income peaked at $10.8 million in Q4 2024 and troughed at -$1.1 million in Q3 2024.
- A 4-year average of $2.1 million and a median of $1.6 million in 2023 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2023 and 2024: Non Operating Income surged 953.66% in 2023, then slumped 153.1% in 2024.
- Over 4 years, Non Operating Income stood at $538000.0 in 2022, then soared by 319.52% to $2.3 million in 2023, then surged by 378.02% to $10.8 million in 2024, then tumbled by 83.86% to $1.7 million in 2025.
- According to Business Quant data, Non Operating Income over the past three periods registered $1.7 million, $6.0 million, and -$82000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -53.64 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -51.63 Mn |
| 10 | ImageneBio | 47.79 Mn | -87.56 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.74 Mn |
| Jun 30, 2025 | 6.00 Mn |
| Mar 31, 2025 | -82,000.00 |
| Dec 31, 2024 | 10.79 Mn |
| Sep 30, 2024 | -1.15 Mn |
| Jun 30, 2024 | 2.16 Mn |
| Mar 31, 2024 | 2.11 Mn |
| Dec 31, 2023 | 2.26 Mn |
| Sep 30, 2023 | 2.16 Mn |
| Jun 30, 2023 | 1.38 Mn |
| Mar 31, 2023 | 1.30 Mn |
| Sep 30, 2022 | 538,000.00 |
| Jun 30, 2022 | 460,000.00 |
| Mar 31, 2022 | 123,000.00 |